Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immunologic system is a complex network of cells, tissues, and organs that work together to defend the body against foreign invaders, such as bacteria, viruses, and parasites, while maintaining self-tolerance (StatPearls, NBK459471). It is broadly divided into the innate immune system, which provides immediate, non-specific defense, and the adaptive immune system, which offers highly specific, long-lasting protection (NIH, NBK279364). In a therapeutic context, the immunologic system is not a single target but rather a collection of thousands of potential molecular targets, including receptors, cytokines, and signaling enzymes. Dysregulation of this system leads to a wide range of pathologies, including autoimmune disorders, chronic inflammation, and increased susceptibility to infections or cancer. Drugs typically modulate specific components of the system—such as TNF-alpha inhibitors for rheumatoid arthritis or checkpoint inhibitors for oncology—rather than targeting the system as a whole.
Not applicable as this refers to a whole physiological system rather than a specific molecular target.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunologic system.